Homepage arrow_right Deals & Advisory arrow_right Mergers & Acquisitions arrow_right Pfizer Acquires Medivation, Inc.

Pfizer Acquires Medivation, Inc.

Mergers & Acquisitions

Pfizer (NYSE: PFE), multinational pharmaceutical company, acquired Medivation, Inc. (Nasdaq: MDVN), a biopharmaceutical company, for $14 billion.

Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.

Find more information here.